Received Dec 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | 2 | YE232 | IM / LA |
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 929PN | IM / RA |
Patient received one dose of Arexvy on 12/23/23 and a second dose on 12/3/25. Currently, only one dose per lifetime is recommended. Spoke with patient and he reported no adverse effects.